Angiotensin Receptor Blockers and Dementia Prevention: Do Not RAS to a Conclusion Yet.
作者信息
Yasar Sevil, Wharton Whitney
机构信息
Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD (S.Y.).
School of Nursing, Emory University, Atlanta, GA (W.W.).
出版信息
Hypertension. 2022 Oct;79(10):2170-2172. doi: 10.1161/HYPERTENSIONAHA.122.19859. Epub 2022 Sep 7.
Abstract
摘要
相似文献
1
Angiotensin Receptor Blockers and Dementia Prevention: Do Not RAS to a Conclusion Yet.血管紧张素受体阻滞剂与痴呆症预防：目前切勿仓促下结论。
Hypertension. 2022 Oct;79(10):2170-2172. doi: 10.1161/HYPERTENSIONAHA.122.19859. Epub 2022 Sep 7.
2
Blockers of the renin-angiotensin-aldosterone system: almost, but not yet, an absolute weapon against cardiovascular and renal diseases!肾素-血管紧张素-醛固酮系统阻滞剂：近乎但尚未成为对抗心血管疾病和肾脏疾病的绝对武器！
J Renin Angiotensin Aldosterone Syst. 2012 Mar;13(1):216. doi: 10.1177/1470320312438138.
3
Prevention of dementia by ACE inhibitors and angiotensin receptor blockers - potential but not proven.
Int J Clin Pract. 2010 Nov;64(12):1595-8. doi: 10.1111/j.1742-1241.2010.02490.x.
4
Mitigation of radiation injuries via suppression of the renin-angiotensin system: emphasis on radiation nephropathy.通过抑制肾素-血管紧张素系统减轻辐射损伤：重点关注辐射肾病。
Curr Drug Targets. 2010 Nov;11(11):1423-9. doi: 10.2174/1389450111009011423.
5
Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).使用血管紧张素转换酶（ACE）抑制剂和血管紧张素受体阻滞剂（ARB）对肾素-血管紧张素系统进行双重阻断。
Br J Clin Pharmacol. 2011 Mar;71(3):313-5. doi: 10.1111/j.1365-2125.2011.03918.x.
6
Renin-angiotensin system blockade use and risks of cognitive decline and dementia: A meta-analysis.肾素-血管紧张素系统阻断剂的使用与认知功能下降和痴呆的风险：一项荟萃分析。
Neurosci Lett. 2016 Jun 15;624:53-61. doi: 10.1016/j.neulet.2016.05.003. Epub 2016 May 6.
7
Association between renin-angiotensin-aldosterone system inhibitors and risk of dementia: A meta-analysis.血管紧张素-肾素-醛固酮系统抑制剂与痴呆风险的关系：一项荟萃分析。
Pharmacol Res. 2021 Apr;166:105515. doi: 10.1016/j.phrs.2021.105515. Epub 2021 Feb 24.
8
New approaches to blockade of the renin-angiotensin-aldosterone system: evidence from randomized controlled trials (RCTs) of angiotensin-converting enzyme inhibitors and angiotensin II-receptor blockers--questions remain unsolved.阻断肾素-血管紧张素-醛固酮系统的新方法：来自血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的随机对照试验 (RCT) 的证据——仍存在未解决的问题。
J Pharmacol Sci. 2010;113(4):292-5. doi: 10.1254/jphs.10r08fm. Epub 2010 Jul 27.
9
Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.肾素-血管紧张素-醛固酮系统抑制剂对 COVID-19 的影响。
Hypertens Res. 2022 Jul;45(7):1147-1153. doi: 10.1038/s41440-022-00922-3. Epub 2022 May 18.
10
Renin-angiotensin-aldosterone system inhibitors in heart failure.肾素-血管紧张素-醛固酮系统抑制剂在心力衰竭中的应用。
Clin Pharmacol Ther. 2013 Oct;94(4):459-67. doi: 10.1038/clpt.2013.135. Epub 2013 Jul 12.
引用本文的文献
1
Angiotensin Receptor Blockers and Cognition: a Scoping Review.血管紧张素受体阻滞剂与认知：范围综述。
Curr Hypertens Rep. 2024 Jan;26(1):1-19. doi: 10.1007/s11906-023-01266-0. Epub 2023 Sep 21.
本文引用的文献
1
Angiotensin Receptor Blockers Are Associated With a Lower Risk of Progression From Mild Cognitive Impairment to Dementia.血管紧张素受体阻滞剂与轻度认知障碍进展为痴呆的风险降低相关。
Hypertension. 2022 Oct;79(10):2159-2169. doi: 10.1161/HYPERTENSIONAHA.122.19378. Epub 2022 Jun 29.
2
Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment: A Randomized Clinical Trial.坎地沙坦与赖诺普利对执行轻度认知障碍老年人神经认知功能的影响：一项随机临床试验。
JAMA Netw Open. 2020 Aug 3;3(8):e2012252. doi: 10.1001/jamanetworkopen.2020.12252.
3
Hypertension and the Risk of Dementia.高血压与痴呆症风险
Front Cardiovasc Med. 2020 Jan 31;7:5. doi: 10.3389/fcvm.2020.00005. eCollection 2020.
4
Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis.抗高血压药物种类、痴呆与认知能力下降的关系：一项荟萃分析。
Neurology. 2020 Jan 21;94(3):e267-e281. doi: 10.1212/WNL.0000000000008732. Epub 2019 Dec 11.
5
Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies.抗高血压药物与新发痴呆和阿尔茨海默病风险的关系：来自前瞻性队列研究的个体参与者数据的荟萃分析。
Lancet Neurol. 2020 Jan;19(1):61-70. doi: 10.1016/S1474-4422(19)30393-X. Epub 2019 Nov 6.
6
Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives.神经原纤维缠结与某些抗高血压药物对轻度认知障碍的转化。
J Alzheimers Dis. 2019;70(1):153-161. doi: 10.3233/JAD-190011.
7
The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity.多种降压药物类别与性别、种族和民族的阿尔茨海默病发病率的关联。
PLoS One. 2018 Nov 1;13(11):e0206705. doi: 10.1371/journal.pone.0206705. eCollection 2018.
8
The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?阿尔茨海默病中血管紧张素假说的发展：疾病预防和治疗的进展？
J Alzheimers Dis. 2018;62(3):1443-1466. doi: 10.3233/JAD-171119.
9
Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.定义高血压、认知衰退与痴呆症之间的关系：一项综述
Curr Hypertens Rep. 2017 Mar;19(3):24. doi: 10.1007/s11906-017-0724-3.
10
Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials.抗高血压药物与认知障碍之间的关系：第一部分。人体研究与临床试验综述。
Curr Hypertens Rep. 2016 Aug;18(8):67. doi: 10.1007/s11906-016-0674-1.
Zotero 插件